RBC Capital Upgrades Biocryst Pharmaceuticals (BCRX)
18/9 22:40
Fintel reports that on September 18, 2023, RBC Capital upgraded their outlook for Biocryst Pharmaceuticals (NASDAQ:BCRX) from Sector Perform to Outperform ....
|
|
|
18/9 22:40
Fintel reports that on September 18, 2023, RBC Capital upgraded their outlook for Biocryst Pharmaceuticals (NASDAQ:BCRX) from Sector Perform to Outperform ....